MAR 07, 2017 6:57 PM PST

Another Step Forward in the Fight Against Breast Cancer

WRITTEN BY: Carmen Leitch

Cancer is most deadly when it spreads from the part of the body where it formed to another part, metastasis. Breast cancer patients are killed not because of breast cancer recurrence, but because it metastasizes; migration to the brain is deadliest for the patient. Researchers at City of Hope have learned more about brain metastases in women suffering from HER-2 positive breast cancer. Around 40 percent of HER-2 positive breast cancers (explained in the video below from the Dana-Farber Cancer Institute) go on to experience brain metastases. Understanding more about the mechanism behind this event will help inform new treatments.

"More women than ever are surviving breast cancer only to die from breast tumors growing in their brains years after they've been declared cancer-free," explained the leader of the study,  Rahul Jandial, M.D., Ph.D., a neurosurgeon and scientist at City of Hope. "I wanted to understand why women with HER2-positive breast cancer (around 20 percent of all breast cancers) have higher rates of brain metastases than women with other breast cancer subtypes and in turn, find their biological Achilles heel to develop new medicines." This work is set to be reported in Clinical & Experimental Metastasis, the journal of the Metastases Research Society.

A protein called reelin that is typically only found in the brain, also encases breast cancer cells, which acts as a shield preventing detection of the cancerous cells. The cells are able to avoid protective mechanisms used by the brain and can then take hold. From their, a dangerous brain tumor can begin to grow.

Following brain surgery, Jandial and his team were able to use the tissue samples remaining after the surgery, comparing those specimens to breast cancer tissue obtained during mastectomies that the same patients had undergone. The investigators found that expression of the reelin protein was low in tissue from primary breast cancer, but in breast cancer that was HER-2 positive and had metastasized to the brain, reel in expression was significantly higher. 

"The cells are essentially able to act as spies that look like citizens," explained Jandial. "They release a mesh of protein and escape the brain's natural defense weapons, causing tumors to grow in the brain."

90 percent of all cancer deaths result from metastases; people that are diagnosed with metastases in the brain have only a 20 percent chance of living a year after their diagnosis. This work will hopefully help patients afflicted with cancer, especially those with metastatic breast cancer.

Metastatic Breast Cancer in Pleural Fluid / Credit: Ed Uthman/Flickr

 

Sources: AAAS/Eurekalert! via City of Hope, Clinical & Experimental Metastasis

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
AUG 01, 2021
Genetics & Genomics
Rethinking the Cause of Mutations That Lead to Melanoma
AUG 01, 2021
Rethinking the Cause of Mutations That Lead to Melanoma
Throughout our lives, new cells often replace the ones that become damaged or worn out. As cells divide, they have to re ...
AUG 20, 2021
Drug Discovery & Development
Blood Pressure Drugs Boost Survival in Colorectal Cancer
AUG 20, 2021
Blood Pressure Drugs Boost Survival in Colorectal Cancer
Common drugs used to regulate blood pressure may improve survival rates among patients with colorectal cancer, also know ...
SEP 06, 2021
Cancer
A New Biomarker to Personalize Breast Cancer Therapy
SEP 06, 2021
A New Biomarker to Personalize Breast Cancer Therapy
The American Cancer Society estimates that over 280,000 women in the United States will be diagnosed with breast cancer ...
OCT 14, 2021
Cancer
Mechanism of Resistance to Colorectal Cancer Treatment Uncovered
OCT 14, 2021
Mechanism of Resistance to Colorectal Cancer Treatment Uncovered
Colorectal cancer develops when a series of changes occur across multiple genes.  While researchers have paid signi ...
NOV 05, 2021
Cancer
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
NOV 05, 2021
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
Every year, Labroots hosts an exciting series of Virtual Events that focus on various scientific topics. These virtual m ...
NOV 18, 2021
Immunology
Ultrasound Helps Shuttle Cancer-Killing Antibodies to the Brain
NOV 18, 2021
Ultrasound Helps Shuttle Cancer-Killing Antibodies to the Brain
Antibody therapies harness the immune system's power to fight a broad spectrum of diseases, from cancer to infectiou ...
Loading Comments...